Han Kook Chung

Title: Han Kook Chung: Innovator in Pharmaceutical Chemistry

Introduction

Han Kook Chung is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific health conditions. His work is characterized by a focus on innovative solutions to complex medical challenges.

Latest Patents

Han Kook Chung holds a patent for an oxazolidinone derivative that acts as a CETP inhibitor. The patent, titled "Oxazolidinone derivative as CETP inhibitor, its preparation method, and pharmaceutical composition comprising the same," describes a novel compound that exhibits excellent inhibitory activity against CETP. This compound can be effectively utilized in the prevention or treatment of various diseases related to CETP enzyme activity and HDL cholesterol levels, such as dyslipidemia, atherosclerosis, and coronary heart disease. He has 1 patent to his name.

Career Highlights

Han Kook Chung is associated with Dong-A ST Co., Ltd., a company known for its commitment to advancing pharmaceutical research and development. His role at the company has allowed him to contribute to innovative projects that aim to improve health outcomes for patients.

Collaborations

Throughout his career, Han Kook Chung has collaborated with talented professionals in the field. Notable coworkers include Jang Hyun Park and Seung Hyun Song, who have worked alongside him on various projects.

Conclusion

Han Kook Chung's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his commitment to addressing critical health issues. His work continues to pave the way for advancements in medical treatments and therapies.